MODIFIED PERCUTANEOUS TRANSLUMINANT SEPTAL MYOCARDIA ABLATION: A NEW METHOD FOR HYPERTROPHIC CARDIOMYOPATHY MANAGEMENT

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HASHEMI M.; FARHAD M.; NASR A.; SHIRANI SH.; SHAMSOLKETABI H.; HEIDARI R.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS) Year:2001 | Volume:6 | Issue:2 Page(s): 141-143

Download Full-Text

Persian Verion

View:

3,101

Download:

Cites:

Information Journal Paper

Title

MODIFIED PERCUTANEOUS TRANSLUMINANT SEPTAL MYOCARDIA ABLATION: A NEW METHOD FOR HYPERTROPHIC CARDIOMYOPATHY MANAGEMENT

Author(s)

Keywords

HYPERTROPHIC CARDIOMYOPATHYQ3

ABLATIONQ3

ALCOHOLQ4

CASE REPORTQ2

SEPTAL ARTERYQ3

Abstract

Introduction. Familial HYPERTROPHIC CARDIOMYOPATHY (HCM) occurs as an autosomal dominant mendelian inherited disease in about 50 percent cases. abstractive and nonobstractive were two forms of HCM. The most common treatment modalities include drug therapy, mitral valve replacement, installation of dual chamber DD pacemaker and surgical excision of a portion of the hypertrophied septum. Methods. One of the newest methods used in recent years for the treatment of HCM unresponsive to common medical procedures is to inject ALCOHOL into SEPTAL ARTERY (septal ABLATION). We used a modified version of this procedure which consisted of using transesophageal echocardiography evaluation of mitral regurgitation and the diagnosis of SEPTAL ARTERY during ALCOHOL injection in a HCM patient. Results. The short term (immediately after procedure) and the long term (after 3 months) evaluation indicates complete improvement of clinical symptoms in the patient. Discussion. Considering the clinical improvement of symptoms, increased tolerance for activity and reduced gradient in LV outflow tract, this procedure is an effective method for the treatment of HCM resistant to common medical therapy.

Cites

No record.

References

No record.

Cite

APA: Copy

HASHEMI, M., FARHAD, M., NASR, A., SHIRANI, SH., SHAMSOLKETABI, H., & HEIDARI, R.. (2001). MODIFIED PERCUTANEOUS TRANSLUMINANT SEPTAL MYOCARDIA ABLATION: A NEW METHOD FOR HYPERTROPHIC CARDIOMYOPATHY MANAGEMENT. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 6(2), 141-143. SID. https://sid.ir/paper/26749/en

Vancouver: Copy

HASHEMI M., FARHAD M., NASR A., SHIRANI SH., SHAMSOLKETABI H., HEIDARI R.. MODIFIED PERCUTANEOUS TRANSLUMINANT SEPTAL MYOCARDIA ABLATION: A NEW METHOD FOR HYPERTROPHIC CARDIOMYOPATHY MANAGEMENT. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2001;6(2):141-143. Available from: https://sid.ir/paper/26749/en

IEEE: Copy

M. HASHEMI, M. FARHAD, A. NASR, SH. SHIRANI, H. SHAMSOLKETABI, and R. HEIDARI, “MODIFIED PERCUTANEOUS TRANSLUMINANT SEPTAL MYOCARDIA ABLATION: A NEW METHOD FOR HYPERTROPHIC CARDIOMYOPATHY MANAGEMENT,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 6, no. 2, pp. 141–143, 2001, [Online]. Available: https://sid.ir/paper/26749/en

Related Journal Papers